BACKGROUND: The utility of combining early markers to predict conversion from mild cognitive impairment (MCI) to Alzheimer's Disease (AD) remains uncertain. METHODS: Included in the study were 148 outpatients with MCI, broadly defined, followed at 6-month intervals. Hypothesized baseline predictors for follow-up conversion to AD (entire sample: 39/148 converters) were cognitive test performance, informant report of functional impairment, apolipoprotein E genotype, olfactory identification deficit, and magnetic resonance imaging (MRI) hippocampal and entorhinal cortex volumes. RESULTS: In the 3-year follow-up patient sample (33/126 converters), five of eight hypothesized predictors were selected by backward and stepwise logistic regression: Pfeffer Functional Activities Questionnaire (FAQ; informant report of functioning), University of Pennsylvania Smell Identification Test (UPSIT; olfactory identification), Selective Reminding Test (SRT) immediate recall (verbal memory), MRI hippocampal volume, and MRI entorhinal cortex volume. For 10% false positives (90% specificity), this five-predictor combination showed 85.2% sensitivity, combining age and Mini-Mental State Examination (MMSE) showed 39.4% sensitivity; combining age, MMSE, and the three clinical predictors (SRT immediate recall, FAQ, and UPSIT) showed 81.3% sensitivity. Area under ROC curve was greater for the five-predictor combination (.948) than age plus MMSE (.821; p = .0009) and remained high in subsamples with MMSE > or = 27/30 and amnestic MCI. CONCLUSIONS: The five-predictor combination strongly predicted conversion to AD and was markedly superior to combining age and MMSE. Combining the clinically administered measures also led to strong predictive accuracy. If independently replicated, the findings have potential utility for early detection of AD.
BACKGROUND: The utility of combining early markers to predict conversion from mild cognitive impairment (MCI) to Alzheimer's Disease (AD) remains uncertain. METHODS: Included in the study were 148 outpatients with MCI, broadly defined, followed at 6-month intervals. Hypothesized baseline predictors for follow-up conversion to AD (entire sample: 39/148 converters) were cognitive test performance, informant report of functional impairment, apolipoprotein E genotype, olfactory identification deficit, and magnetic resonance imaging (MRI) hippocampal and entorhinal cortex volumes. RESULTS: In the 3-year follow-up patient sample (33/126 converters), five of eight hypothesized predictors were selected by backward and stepwise logistic regression: Pfeffer Functional Activities Questionnaire (FAQ; informant report of functioning), University of Pennsylvania Smell Identification Test (UPSIT; olfactory identification), Selective Reminding Test (SRT) immediate recall (verbal memory), MRI hippocampal volume, and MRI entorhinal cortex volume. For 10% false positives (90% specificity), this five-predictor combination showed 85.2% sensitivity, combining age and Mini-Mental State Examination (MMSE) showed 39.4% sensitivity; combining age, MMSE, and the three clinical predictors (SRT immediate recall, FAQ, and UPSIT) showed 81.3% sensitivity. Area under ROC curve was greater for the five-predictor combination (.948) than age plus MMSE (.821; p = .0009) and remained high in subsamples with MMSE > or = 27/30 and amnestic MCI. CONCLUSIONS: The five-predictor combination strongly predicted conversion to AD and was markedly superior to combining age and MMSE. Combining the clinically administered measures also led to strong predictive accuracy. If independently replicated, the findings have potential utility for early detection of AD.
Authors: S De Santi; M J de Leon; H Rusinek; A Convit; C Y Tarshish; A Roche; W H Tsui; E Kandil; M Boppana; K Daisley; G J Wang; D Schlyer; J Fowler Journal: Neurobiol Aging Date: 2001 Jul-Aug Impact factor: 4.673
Authors: M H Tabert; S M Albert; L Borukhova-Milov; Y Camacho; G Pelton; X Liu; Y Stern; D P Devanand Journal: Neurology Date: 2002-03-12 Impact factor: 9.910
Authors: A B Graves; J D Bowen; L Rajaram; W C McCormick; S M McCurry; G D Schellenberg; E B Larson Journal: Neurology Date: 1999-10-22 Impact factor: 9.910
Authors: D H Silverman; G W Small; C Y Chang; C S Lu; M A Kung De Aburto; W Chen; J Czernin; S I Rapoport; P Pietrini; G E Alexander; M B Schapiro; W J Jagust; J M Hoffman; K A Welsh-Bohmer; A Alavi; C M Clark; E Salmon; M J de Leon; R Mielke; J L Cummings; A P Kowell; S S Gambhir; C K Hoh; M E Phelps Journal: JAMA Date: 2001-11-07 Impact factor: 56.272
Authors: Suzanne L Tyas; Juan Carlos Salazar; David A Snowdon; Mark F Desrosiers; Kathryn P Riley; Marta S Mendiondo; Richard J Kryscio Journal: Am J Epidemiol Date: 2007-04-12 Impact factor: 4.897
Authors: D P Devanand; K S Michaels-Marston; X Liu; G H Pelton; M Padilla; K Marder; K Bell; Y Stern; R Mayeux Journal: Am J Psychiatry Date: 2000-09 Impact factor: 18.112
Authors: Deborah Blacker; Hang Lee; Alona Muzikansky; Emily C Martin; Rudolph Tanzi; John J McArdle; Mark Moss; Marilyn Albert Journal: Arch Neurol Date: 2007-06
Authors: Sandip Ray; Markus Britschgi; Charles Herbert; Yoshiko Takeda-Uchimura; Adam Boxer; Kaj Blennow; Leah F Friedman; Douglas R Galasko; Marek Jutel; Anna Karydas; Jeffrey A Kaye; Jerzy Leszek; Bruce L Miller; Lennart Minthon; Joseph F Quinn; Gil D Rabinovici; William H Robinson; Marwan N Sabbagh; Yuen T So; D Larry Sparks; Massimo Tabaton; Jared Tinklenberg; Jerome A Yesavage; Robert Tibshirani; Tony Wyss-Coray Journal: Nat Med Date: 2007-10-14 Impact factor: 53.440
Authors: Laura A van de Pol; Esther S C Korf; Wiesje M van der Flier; H Robert Brashear; Nick C Fox; Frederik Barkhof; Philip Scheltens Journal: Arch Neurol Date: 2007-07
Authors: Richard P Kline; Elizabeth Pirraglia; Hao Cheng; Susan De Santi; Yi Li; Michael Haile; Mony J de Leon; Alex Bekker Journal: Anesthesiology Date: 2012-03 Impact factor: 7.892
Authors: D P Devanand; Ravi Bansal; Jun Liu; Xuejun Hao; Gnanavalli Pradhaban; Bradley S Peterson Journal: Neuroimage Date: 2012-01-25 Impact factor: 6.556
Authors: Alefiya Dhilla Albers; Josephine Asafu-Adjei; Mary K Delaney; Kathleen E Kelly; Teresa Gomez-Isla; Deborah Blacker; Keith A Johnson; Reisa A Sperling; Bradley T Hyman; Rebecca A Betensky; Lloyd Hastings; Mark W Albers Journal: Ann Neurol Date: 2016-11-23 Impact factor: 10.422
Authors: Dara R Adams; Gaurav S Ajmani; Vivian C Pun; Kristen E Wroblewski; David W Kern; L Philip Schumm; Martha K McClintock; Helen H Suh; Jayant M Pinto Journal: Int Forum Allergy Rhinol Date: 2016-09-13 Impact factor: 3.858